Ultragenyx to Host Conference Call for Second Quarter 2026 Financial Results and Corporate Update

Rhea-AI Summary

Ultragenyx (NASDAQ: RARE) will host a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026, to review its financial results and corporate update for the quarter ended June 30, 2026. A live and replay webcast will be accessible via the company’s investor relations website, with the replay available for three months.

Market Context

Tag-specific history showed an average move of -0.01% across 5 events. That record places this earni...

Analysis

Tag-specific history showed an average move of -0.01% across 5 events. That record places this earnings-date notice in a mixed historical set; recent insider activity was Net Selling and short positioning was moderate.

Key Figures

Announcement date: July 28, 2026 Conference call date: August 4, 2026 Conference call time: 5:00 p.m. ET +2 more

5 metrics

Announcement date July 28, 2026 Article publication date

Conference call date August 4, 2026 Second-quarter 2026 results call

Conference call time 5:00 p.m. ET August 4, 2026

Quarter end June 30, 2026 Quarter covered by the upcoming financial results

Replay availability three months Conference call replay

Previous Conferences,earnings date Reports

5 past events · Latest: Apr 29 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 29	earnings-date call	Neutral	-1.4%	Scheduled first-quarter 2026 results call and corporate update for May 5.
Feb 05	earnings-date call	Neutral	+3.8%	Scheduled fourth-quarter and full-year 2025 results call for February 12.
Oct 28	earnings-date call	Neutral	-0.5%	Scheduled third-quarter 2025 results call and corporate update for November 4.
Jul 30	earnings-date call	Neutral	-1.9%	Scheduled second-quarter 2025 results call for August 5.
Apr 30	earnings-date call	Neutral	-0.0%	Scheduled first-quarter 2025 results call and corporate update for May 6.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Comparable earnings-date announcements produced mixed reactions from -1.88% to 3.83%, with a tag-specific average move of -0.01%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NOVATO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that it will host a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026, to discuss its financial results and corporate update for the quarter ending June 30, 2026.

The live and replayed webcast of the call will be available through the company’s website at https://ir.ultragenyx.com/events-presentations. The replay of the call will be available for three months.

About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.

For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.

Contact Ultragenyx

Investors
Joshua Higa
ir@ultragenyx.com

Media
Jess Rowlands
media@ultragenyx.com

FAQ

When is Ultragenyx (RARE) reporting its Q2 2026 financial results?

Ultragenyx will discuss its Q2 2026 financial results on a conference call at 5:00 p.m. ET on Tuesday, August 4, 2026. According to Ultragenyx, the call will cover results for the quarter ended June 30, 2026, plus a corporate update.

How can investors access the Ultragenyx (RARE) Q2 2026 earnings conference call webcast?

Investors can access the live and replay webcast of Ultragenyx’s Q2 2026 conference call through the company’s investor relations website at https://ir.ultragenyx.com/events-presentations. According to Ultragenyx, both live and archived streams will be available online for convenient access.

What will Ultragenyx (RARE) discuss during the August 4, 2026 conference call?

Ultragenyx plans to discuss its financial results and provide a corporate update for the quarter ended June 30, 2026. According to Ultragenyx, the August 4, 2026 call will combine quarterly financial commentary with broader business and pipeline developments.

Will a replay of the Ultragenyx (RARE) Q2 2026 earnings call be available to investors?

Yes, a replay of the Ultragenyx Q2 2026 earnings conference call will be available for three months. According to Ultragenyx, the replay can be accessed via the company’s investor relations events and presentations webpage after the live call concludes.

What time is Ultragenyx’s Q2 2026 earnings conference call on August 4, 2026?

Ultragenyx has scheduled its Q2 2026 earnings and corporate update conference call for 5:00 p.m. Eastern Time on Tuesday, August 4, 2026. According to Ultragenyx, this timing allows after-market discussion of the quarter’s financial results and developments.